"I couldn't understand how there was nothing else that could be done."
Zara's dad wasn't eligible for a clinical trial, but she wants things to change for other families.
That's why research matters.
Why test one treatment at a time when you could test several?
That's the idea behind MAMS trials, and why they're a key part of Trial Treat Beat.
But what are MAMS trials? Let us explain.
📺📰 It's been quite a week! Last Monday, we launched Trial Treat Beat, our appeal to help fund innovative clinical trials for people with some of the deadliest blood cancers.
You might have spotted us in the news. We've been busy securing 45 pieces of coverage (and counting)
Our CEO Helen Rowntree & Ambassador Shaline spoke live on ITV London News, while our Director of Research, Policy & Services, Rubina Ahmed, appeared on The World Today with Maryam Moshiri.
Because behind every headline, every statistic, and every clinical trial are real people.
1
1
269
More people are surviving cancer than ever before.
But if you’re diagnosed with one of the deadliest blood cancers, your chances are just 1 in 3.
But a breakthrough is coming 🔬
Trial Treat Beat is our £25m game-changing plan to double survival chances, through three innovative clinical trials.
This means that treatments which aren’t working can be stopped early, while promising treatments move forward more quickly.
1
5
260
We brought people affected by the deadliest blood cancers together to share why our new appeal, Trial Treat Beat, matters to them ❤️
‼️ For too long, people with some of the deadliest blood cancers have been left behind by progress.
We want to change that.
We're aiming to raise £25 million to fund groundbreaking clinical trials that could help double survival rates and give more people a better chance of life after a blood cancer diagnosis.
Find out more about Trial Treat Beat here ➡️ bit.ly/4syT8vj
📢‼️ We placed 99 chairs in central London to mark the launch of Trial Treat Beat.
Our new appeal to help double survival chances for people with the deadliest blood cancers.
We want to raise £25 million to fund game-changing clinical trials that could help find effective treatments faster, and give more people a better chance of survival.
It’s a big ambition, and we can’t do it alone.
1
4
215
Teresa and Carole were diagnosed with lymphoma, so they know what it’s like to go through blood cancer treatment.
Now they use their experience to help shape the research we fund
@NIHRinvolvement
1/5
📣 We're committed to ensuring the voices and experiences of people affected by blood cancer are helping to shape blood cancer research.
Because together we will beat blood cancer.
5/5
1
1
153
Read more about bringing different expertise together, and shared commitment here: bit.ly/48hgex8
1
125




